We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Empaveli Swedish Orphan Biovitrum Pty Ltd
Product name
Empaveli
Sponsor
Accepted date
Jul-2024
Active ingredients
pegcetacoplan
Proposed indication
For the treatment of paroxysmal nocturnal haemoglobinuria.
Application type
C (new indication)
Publication date
Jul-2024